Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07192601 · ClinicalTrials.gov registry record · NA
Developing an E-Cigarette Cessation Intervention for Hispanic/Latina(o) Youth in Florida: The BReATHE Study
A NA study of Tobacco Use Disorder and Vaping Behaviors, sponsored by Florida International University.
- Active
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT07192601: Active NA study of Tobacco Use Disorder and Vaping Behaviors, sponsored by Florida International University.
NCT07192601 is a NA study of Tobacco Use Disorder and Vaping Behaviors that is active but no longer recruiting, run by Florida International University. The registered enrollment target is 120 participants, below the 238-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07192601, a NA study of Tobacco Use Disorder and Vaping Behaviors, is active but no longer recruiting, sponsored by Florida International University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
Investigators will create and implement an e-cigarette intervention for Hispanic/Latino (H/L) high school youth. Focus groups with the target population (i.e., H/L high school students) and meetings with a community advisory board (CAB) will inform this intervention. The intervention will be tested with 120 H/L high school e-cigarette users to assess feasibility and promise for reducing use.
Primary Outcome
This measure assesses the timing, brand, flavoring, quantity, and frequency of current and past e-cigarette use.
Conditions Studied
Interventions
- BEHAVIORAL E-cigarette Cessation Manual
Study Locations (1)
Florida
- FIU Center for Children and Families - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2024-05-01 |
| Est. Completion | 2028-04-30 |
| Phase | NA |
What the registry record for NCT07192601 still lists
NCT07192601 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 238-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target (50% lower).
The record links to 4 conditions, with Tobacco Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which E-cigarette Cessation Manual is the first listed.
NCT07192601 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT07192601 about?
NCT07192601 is a clinical study titled "Developing an E-Cigarette Cessation Intervention for Hispanic/Latina(o) Youth in Florida: The BReATHE Study". Investigators will create and implement an e-cigarette intervention for Hispanic/Latino (H/L) high school youth. Focus groups with the target population (i.e., H/L high school students) and meetings with a community advisory board (CAB) will inform this intervention. The intervention will be tested ...
What is the current status of trial NCT07192601?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2024-05-01. Estimated completion is 2028-04-30.
What conditions does trial NCT07192601 study?
This clinical trial studies the following conditions: Tobacco Use Disorder, Vaping Behaviors, Vaping Teens, Vaping Cessation.
What interventions are being tested in trial NCT07192601?
The interventions under investigation include: E-cigarette Cessation Manual (BEHAVIORAL).
Who is sponsoring clinical trial NCT07192601?
This trial is sponsored by Florida International University, which has 89 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07192601 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07192601's enrollment target sits among peer trials
120 34th of 70 higher than 36 of 70 other Tobacco Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tobacco Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Smoking Cessation CM for Veterans With or at Risk for Cancer
RECRUITING · NA
-
Smoking Cessation Behavioral Treatment Study
RECRUITING · NA
-
Contingency Management for Veteran Smokers Undergoing Major Elective Surgery
RECRUITING · NA
-
A Future Thinking Intervention for Comorbid Tobacco Use Disorder and Bipolar Disorder
RECRUITING · NA
-
Young Adult Tobacco/Nicotine and Cannabis Co-use
RECRUITING · NA
-
Low Intensity Focused Ultrasound for Tobacco Use Disorder: High Resolution Targeting of the Human Insula
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI